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High-resolution HIV-1 genotyping of large sample sets is crucial to define the evolving and dynamic epidemics in Asia. Here we presentMHAbce
v.2, a multi-region hybridization assay that individually discriminates subtypes B, C, CRF01_AE, and virtually all of their described recombinants,
based on real-time PCR using subtype-specific TaqMan probes in 8 regions throughout the viral genome. In a validation panel (n=70), the assay
performed with a sensitivity of 95.7% and specificity of 99.8%. The assay was field-tested on samples from a retrospective MTCT cohort (n=180;
Lampang Province, Northern Thailand; 1996–1998). 177/180 of the samples were typeable, and 94.4% were typed as CRF01_AE. The remaining
strains represented even proportions of subtype B and B/CRF01_AE recombinants and were confirmed by sequencing, revealing early links between
the heterosexual and IDU HIV-1 epidemics in Thailand. MHAbce v.2, with an area of application including China, India, Southeast Asia, and the
Pacific Rim, can be used to develop a comprehensive and detailed picture of this important component of the HIV/AIDS pandemic.
Published by Elsevier Inc.Keywords: HIV-1; Molecular epidemiology; Multi-region hybridization assay (MHA); Recombinant forms; Asia; ThailandIntroduction
Asia is home to almost half of the world's population and
harbors one in five global Human Immunodeficiency Virus type
1 (HIV-1) infections (UNAIDS, 2006). Nine genetic subtypes
and many inter-subtype recombinant forms circulate in the
pandemic (Kijak and McCutchan, 2005; McCutchan, 2006;⁎ Corresponding author. Fax: +1 301 762 7460.
E-mail address: gkijak@hivresearch.org (G.H. Kijak).
1 Current address: Centers for Disease Control and Prevention, Atlanta, GA,
USA.
0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2006.07.055Peeters and Sharp, 2000), but the genetic diversity of HIV-1 in
Asia is only a subset of this global diversity (Tovanabutra et al.,
2004a, 2004b). Identification of HIV-1 strains in Asia is
fundamental to the selection and evaluation of candidate
vaccines (Thomson et al., 2002) and is important to monitor
development of antiretroviral drug resistance in different
subtypes (Wainberg, 2004). Molecular epidemiology has been
widely applied on the continent in an effort to document the
diversity of strains and their geographic distribution (reviewed in
Tovanabutra et al., 2004a, 2004b).
Genotyping of HIV-1 can identify strains associated with
particular risk behaviors, providing focus for intervention, and can
179G.H. Kijak et al. / Virology 358 (2007) 178–191reveal the social networks, often transcending national borders, in
which HIV-1 spreads (Avila et al., 2002; Kalish et al., 1995).
Moreover, the spread of new molecular forms, often generated
through inter-subtype recombination in high-risk groups multiply
exposed to HIV-1, can be specifically addressed to limit the
growing complexity of the Asian epidemic (Delgado et al., 2002;
Liitsola et al., 1998; Piyasirisilp et al., 2000; Rodenburg et al.,
2001; Takebe et al., 2003; Tovanabutra et al., 2003). Finally, the
design and evaluation of candidate vaccines will be facilitated by a
complete description of the circulating strains.
Nucleotide sequences drawn from more than 13,000 HIV-1
strains from Asia are available, but only 1% of these se-
quences encompass the complete HIV-1 genome (http://www.
hiv.lanl.gov). The overwhelming majority of HIV-1 sequences
from Asia, partial or complete, are either subtype B, subtype C
or CRF01_AE, a circulating recombinant form (CRF) com-
bining subtypes A and E (Carr et al., 1996; Gao et al., 1996;
Tovanabutra et al., 2004a, 2004b). Recombinants of these
strains are also being documented inmany countries (Piyasirisilp
et al., 2000; Ramos et al., 2002; Rodenburg et al., 2001; Takebe
et al., 2003; Tee et al., 2005; Tovanabutra et al., 2003, 2004a,
2004b, 2005), but the power to identify and track novel recom-
binant forms has been largely vested in the complete genome
sequencing approach, at least to date (Carr et al., 1999; Salminen
et al., 1995b).
The challenge formolecular epidemiology ofHIV-1 inAsia is
to provide enough genetic information per strain to distinguish
the three principal strains from the recombinants derived from
them, while providing adequate sampling of large numbers of
HIV-1 positive individuals. Complete genome sequencing of a
sufficient number of strains is impractical, but multi-region
hybridization assays (MHAs) that use fluorescent, subtype-
specific probes applied to multiple genome regions per strain
have provided an adequate alternative technology in several
complex, regional epidemics outside Asia (Arroyo et al., 2005;
Hierholzer et al., 2002; Hoelscher et al., 2002; Kijak et al., 2004).
The objective of this study is to design, validate, and apply a
high-throughput, fluorescent genotyping assay, MHAbce v.2,
constructed specifically to distinguish all of the known
molecular forms of HIV-1 in Asia, now numbering thirty.
Such an approach could provide more accurate estimates of the
proportions of strains, track rare strains that may begin to
circulate widely, and identify new molecular forms as they arise.
Here we report the design, validation, and first field application
of MHAbce v.2 and show its potential to track the Asian HIV-1
epidemic with improved scope and clarity.
Results
Design of an HIV-1 genotyping assay for Asia
The objective of this study is to design, validate, and field test
a high-throughput genotyping assay capable of distinguishing
the known HIV-1 subtypes, circulating recombinant forms
(CRFs) and unique recombinant forms (URFs) in Asia. Current
knowledge of the genetic diversity of HIV-1 in Asia provided the
basis for assay design. Published complete or virtually completegenome sequences fromHIV-1 infections in China, India, Japan,
Korea, Myanmar, and Thailand, together with partial sequences
from these countries and from Bangladesh, Cambodia, Malay-
sia, Nepal, The Philippines, Singapore, and Taiwan were
available for analysis (http://www.hiv.lanl.gov).
Fig. 1 indicates the region of Asia targeted for assay design
and shows the subtype distribution and country of origin of
HIV-1 strains in the complete genome database. The complexity
of strains in the Asia epidemic is depicted in Fig. 1b. Virtually
all of the HIV-1 infections characterized by complete or partial
sequencing are either subtype B, subtype C, or CRF01_AE or
are recombinants of these. CRFs combining subtypes B and C
(CRF07_BC, CRF08_BC) (Piyasirisilp et al., 2000; Rodenburg
et al., 2001) or subtype B and CRF01_AE (CRF15_01B)
(Tovanabutra et al., 2003) have been identified, along with 18
unique B/CRF01_AE recombinant forms (Ramos et al., 2002;
Takebe et al., 2003; Tovanabutra et al., 2004a, 2004b, 2005;
Watanaveeradej et al., 2006), an apparent CRF07/CRF08
recombinant (Yang et al., 2003), two unique B/C recombinants
(Takebe et al., 2003), one unique C/CRF01_AE recombinant
(Watanaveeradej et al., 2003), and two B/C/CRF01_AE
recombinants (Takebe et al., 2003).
Development of an MHAwith genotyping capacity for Asia
will require the design and validation of fluorescent probes
specific for subtypes B, C, and CRF01_AE. Fig. 1c highlights
the additional requirement for characterization of multiple
genome regions per strain to meet the objective of distinguishing
the many different recombinant forms. The genome location of
probes will be an important consideration. For example, the
vertical lines in Fig. 1c represent the locations of eight subtype-
specific probe sets that, together, would develop hybridization
patterns across the genome that would specifically distinguish
virtually all of molecular forms of HIV-1 known to exist in Asia.
Subtype-specific probes
Development of the MHAbce v.2 requires probes designed
for optimal recognition of the homologous subtype or CRF, with
minimal cross reaction on heterologous subtypes/CRF. Another
goal is the design of inner and outer PCR primers that can
achieve universal amplification of all relevant HIV-1 subtypes/
CRF. For probe and primer design, an alignment of virtually
complete HIV-1 sequences from SE Asia and neighboring
countries was used to identify regions of clustered within-
subtype conservation and between-subtype variation in the eight
regions of HIV-1 genome depicted in Fig. 1c.
Discrimination between subtypes/CRF depends on the
generation of probe/target DNA duplexes that are stable at the
annealing/extension temperature used for real-time PCR for the
homologous subtype/CRF, but not for heterologous subtypes/
CRF. The thermal stability of duplexes can be predicted, in part,
from the length and base composition, but the actual effects of
probe/target mismatches can be strongly dependent on sequence
context and the nature and distribution of mismatches (Turner,
1996), and on electrolyte and detergent concentrations. Each
candidate probe was tested empirically for its performance on
homologous and heterologous target sequences.
Fig. 1. Development of the MHAbce v.2. (a) The intended geographic area of application of MHAbce v.2 is shown. (b) The distribution by country and by clade of full-
genome HIV-1 sequences from Asia, based on 119 reported sequences (Los Alamos National Laboratory, http://www.hiv.lanl.gov). Only one sequence per individual
was considered. (c) Genetic structure of molecular forms of HIV-1 fromAsia containing CRF01_AE (black), subtype B (gray), or subtype C (white). Vertical bars depict
the 8 regions of the HIV-1 genome where MHAbce v.2 probes hybridize.
180 G.H. Kijak et al. / Virology 358 (2007) 178–191Candidate oligonucleotide probes were initially synthesized
without the fluorescent dye and quencher required for use in
TaqMan real-time PCR (“cold probes”), together with com-
plementary unlabeled oligonucleotides representing homolo-gous and heterologous target sequences. Hybridization was
performed under conditions to be used in real-time PCR and in
the presence of SybrGreen, whose fluorescence intensity is
enhanced when bound to double-stranded DNA. Thermal
181G.H. Kijak et al. / Virology 358 (2007) 178–191dissociation profiles of the probe/target duplexes were then
evaluated using SybrGreen fluorescence.
Many of the candidate probes provided the desired dis-
crimination. Fig. 2a shows a CRF01_AE-specific probe that
forms duplexes with melting temperatures (Tms) well above
the 60 °C annealing/extension temperature with a CRF01_AE
target sequence, but of much lower Tm with subtype B or C.
In other cases, the subtype discrimination of probes needed to
be improved. We used ad hoc introduction of an additional
mismatched base, not represented in the target sequences, to
improve discrimination (Kijak et al., 2004; Plantier et al.,
2002). Fig. 2b shows an example of improved specificity. Once
all 24 probes (3 subtypes×8 genome regions) had been identified,
inner and outer PCR primers were designed in areas of
complete or near-complete sequence conservation closely
flanking the probe sites. Primers were tested empirically for
their ability to amplify all of the relevant subtypes and CRFFig. 2. Thermal dissociation profiles of DNA duplexes of homologous and heterologou
probe was incubated with CRF01_AE (solid black line), subtype B (gray line), and su
melting temperatures (Tms) made this candidate a suitable probe. (b) A CRF01_AE-sp
(plain lines). The limited separation between Tms made this candidate unsuitable. Th
additional mismatched base (lines with symbols) provided a better separation pred
extension temperature (60 °C, bar). See text for details.(data not shown). The nucleotide sequences of the primers and
probes for the MHAbce v.2 assay are given in Table 1.
Assay validation
The performance of MHAbce v.2 was evaluated on a panel
of 70 samples for which the complete nucleotide sequence had
been determined (Table S1), representing the subtypes, CRFs,
and URFs circulating in SE Asia and neighboring countries.
The target sequences were in the form of uncloned PCR
products that had been used for complete genome sequencing
or, in the case of subtype C from India, were amplified from
complete HIV-1 genomes cloned in plasmid vectors.
First, 53 samples from the panel representing pure subtype B,
C, or CRF01_AE strains were evaluated. Probes for subtype B,
subtype C, and CRF01_AE performed with high sensitivity and
specificity. The reactions with heterologous subtypes,s targets of candidate real-time PCR probes. (a) A CRF01_AE-specific candidate
btype C (dotted line) targets. Separation between homologous and heterologous
ecific candidate probe was incubated with homologous and heterologous targets
e same CRF01_AE-specific candidate probe with the ad hoc introduction of an
icting that with the homologous probe will form stable duplexes at annealing/
Table 1
Primers and probes used in MHAbce v.2
Sequence (5′–3′)
Region p17
Outer primers
Forward AGACAGGAWCAGARGAACTTARATCATT
Reverse ACCCATGCATTYAAAGTTCTAGGTG
Inner primers
Forward CCAARGAAGCYTTAGANAARATAGAGGAAG
Reverse TGCCCTTGKRSATTYTGCACTATAGG
Probes (HXB2: 1133–1163)
CRF01_AE FAM-CAGCAGGCAGCAGCAGGCAAAGGAAGCAG-BHQ1
Subtype B FAM-CACAGCAAACAGCAGCAGRCATAGGAAACAR-BHQ1
Subtype C FAM-CACAGCAGGCAAAAGARGCTAACGGGAA-BHQ1
Region pro
Outer primers
Forward AGGCCRGGRAATTTYCYTCAG
Reverse TCATTTTTGGTTTCCATYTTCCTGG
Inner primers
Forward CAGAGCAGACCAGAGCCAACAGC
Reverse TTCCTGGCAAATTYAYNTCTTCTAATAC
Probes (HXB2: 2268–2298)
CRF01_AE FAM-TGGCAACGTCCCCTTGTCACAGTAAAAATAG-BHQ1
Subtype B FAM-TGGCAACGTCCTCTCGTCACAATAAAGATAG-BHQ1
Subtype C FAM-TGGCAGCGTCCCCTTGTCTCAATAAGAGTAG-BHQ1
Region rt
Outer primers
Forward TTYTGGGAAGTTCAATTAGGAATACC
Reverse AAGTCATCCATGTATTGATAGATAACYATKTCTGG
Inner primers
Forward GGGNGATGCATATTTYTCAGTTCCTTT
Reverse YYCTAAARGGCTCTAAGATTTTTGTCATGC
Probes (HXB2: 2968–2999)
CRF01_AE FAM-CAGGAATCAGATTTCAGTACAATGTGCTGCCA-BHQ1
Subtype B FAM-CAGGGATTAGATATCAGTACAATGTGCTTCCA-BHQ1
Subtype C FAM-CAGGGATTAGGTATCAATATAATGTGCTTCCA-BHQ1
Region int
Outer primers
Forward AAAATTAGCAGGAAGATGGCCAG
Reverse CTGTCCTTAAGRTGYTCAGCTTG
Inner primers
Forward GTTAARGCMGCCTGTTGGTGG
Reverse CTACTCCYTGACTTTGGGGATTGTA
Probes (HXB2: 4622–4645)
CRF01_AE FAM-AATTCCTGTTGGACATTGGCCCAC-BHQ1
Subtype B FAM-AATTCCTGCTTGATCCCCGCCCAC-BHQ1
Subtype C FAM-AATTCCTGTTGGATACCTGCCCAC-BHQ1
Region tat
Outer primers
Forward TGCAACAACTRCTGTTTRTTCATTTC
Reverse TACTATRGTCCACACAACTATTGCTASGA
Inner primers
Forward GAATTGGGTGTCARCATAGCAGAATAGG
Reverse TGYYCCCGCTTCTTCCTGCCAT
Probes (HXB2: 5918–5946)
CRF01_AE FAM-TGTTGCTGGCATTGCCAAYTATGCTTTCT-BHQ1
Subtype B FAM-TGCTGCTTTCATTGCCAAGTTTGTTTCAT-BHQ1
Subtype C FAM-TGTAGCTACCATTGTCTAGTTTGCTTTCA-BHQ1
Region gp120
Outer primers
Forward GTRGTATCAACTCAAYTRCTGTTAAATGGYAG
Reverse YRATGGGAGGRGCATACATTGC
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Table 1 (continued)
Sequence (5′–3′)
Region gpl20
Inner primers
Forward AACAGGAGAMATAATAGGAGAYATAAGAMAAGCAYATTG
Reverse GGAGGRGCATACATTGCTYKTCC
Probes (HXB2: 7320–7357)
CRF01_AE TET-CAATTAAAATGATGCATTGTAATTTCTAGATCTCCTCC-BHQ1
Subtype B TET-CAATTAAAACTGTGCATTACAATCTCTGGGTCCCCTCC-BHQ1
Subtype C TET-CAATTAAAGCTATGTGTTGTAATTTCTAGGTCCCCTCC-BHQ1
Region gp41/nef
Outer primers
Forward TTCAGCTACCACCGCTTGAGAGACT
Reverse CARTCAGGGAAGWAGCCTTGTG
Inner primers gp41
Forward RRYKGTGGAACTTCTGGGACRCA
Reverse AAGCCCTGTCTNATTCTTSTAGGTATGTKG
Probes gp41 (HXB2: 8675–8704)
CRF01_AE FAM-TCTGTCCACCCCGCTRCTGCTATTGCTRTA-BHQ1
Subtype B FAM-TCTGTCCCYTCAGGTACTGCTATAGCTGTG-BHQ1
Subtype C FAM-TCTGTTCCTTCAGCTACTGCCATTGCTATG-BHQ1
Inner primers nef
Forward ATGGGDRGCAARTGGTCAA
Reverse GCTCCCTTRWAAGTCATTGGTCTTA
Probes nef (HXB2: 8887–8922)
CRF01_AE FAM-TGCTCCATGTTTATCTAGATCTTGCGATACTGCTCC-BHQ1
Subtype B FAM-TGCTCCTTGTTTTTCCAGGTCTCGAGATACTGCTCC-BHQ1
Subtype C FAM-TGCTCCATATTTATCTAAGTCTTGAGACGCTGCTCC-BHQ1
183G.H. Kijak et al. / Virology 358 (2007) 178–191numbering 848 (2 heterologous probes×8 genome regions×53
samples), were uniformly negative, for a specificity of 100%.
Among 424 reactions with homologous probes, 409 hybridized,
for a sensitivity of 96.5% (data not shown). Probe reactivity for
each subtype and region is shown in Supplemental Fig. 1.
The remaining 17 strains in the panel represented
CRF15_01B, CRF08_BC, or URFs. Fig. 3 shows their detailed
structure, and the patterns of probe hybridization observed. In
126 of 136 reactions, the probes hybridized correctly to their
homologous subtype/CRF. Eight reactions were negative, all
due to lack of probe reactivity rather than a failure to amplify, 1
reaction showed dual probe reactivity, and 1 showed only
reactivity with a heterologous probe. The samples exhibiting
dual probe reactivity or heterologous reactivity were URFs, and
it is possible that these derive from individuals infected with
more than one HIV-1 strain.
In summary, the assessment of the 70-sample panel, in-
volving 560 homologous reactions and 1120 heterologous
reactions, showed that the MHAbce v.2 performed with a
sensitivity of 95.7%, a specificity of 99.8%, a positive predictive
value of 99.6%, and a negative predictive value of 97.9%.
HIV-1 subtypes in Lampang Province, Thailand
In the late 1980s, the near-simultaneous introduction of
CRF01_AE in heterosexually acquired HIV-1 infections and
subtype B among intravenous drug users (IDUs) in Thailand set
up a subtype separation by risk group that persisted for some
time (McCutchan et al., 1992; Ou et al., 1992, 1993; Weniger
et al., 1991, 1994). Eventually, these barriers broke down and
CRF01_AE, subtype B, and their recombinants began tocirculate in both IDUs and heterosexuals (Kalish et al., 1995;
Tovanabutra et al., 2003). It is unclear at what stage in the
epidemic the intermixing of strains became significant in the
heterosexual risk group. We selected a retrospective sample set
from 1996 to 1998 for analysis to determine what fraction of
non-CRF01_AE strains could be detected. 180 maternal plasma
samples from a study of mother-to-child HIV-1 transmission
(MTCT) in Lampang Province, Thailand, were evaluated. Viral
RNA extracted from plasma was used as template for the
MHAbce v.2 assay, following a reverse transcription step (see
Materials and methods).
In this retrospective sample set, an average of 7 out of 8
probes hybridized per sample. Fig. 4a shows the subtype
distribution of strains, based on an arbitrary minimum of 4
probes positive to determine a genotype, a criterion that was
attained for 177/180 (98.3%) samples (see also Supplemental
Fig. 2). For 167/177 typed strains (94.4%), all of the probes that
hybridized detected only CRF01_AE. There were 10 strains
(5.6%) for which at least one subtype B or C probe hybridized.
Among the non-CRF01_AE strains, four were classified as
subtype B. Four were B/CRF01_AE recombinants, one of which
had a probe hybridization pattern consistent with CRF15_01B.
One sample showed dual probe reactivity in one of the genome
regions, and one sample hybridized with subtype B, C, and
CFR01_AE probes in different genome regions. Among the 167
CRF01_AE strains, the mean number of genome regions typed
was 7.1, whereas among the non-CRF01_AE strains, the mean
probe reactivity was 6.6 regions (data not shown).
To further characterize the 10 strains that were not
CRF01_AE, complete genome sequencing was performed.
Phylogenetic analysis of virtually complete genome sequences
Fig. 3. Performance of MHAbce v.2 on inter-subtype recombinant strains in the validation panel. The probe reactivity patterns for CRF15_01B, CRF08_BC, B/
CRF01_AEURFs, and C/CRF01_AEURF strains are depicted (circles) below their genetic structure. CRF01_AE and subtypes B and C are represented in red, yellow,
and blue, respectively. Lack of probe reactivity is depicted in white, and dual-probe reactivity is shown with a hatched filling. Dotted lines show probe locations in the
HIV-1 genome.
184 G.H. Kijak et al. / Virology 358 (2007) 178–191(Fig. 4b) showed five subtype B strains, three strains clustering
with CRF01_AE, one CRF15_01B strain, and one outlier strain.
Three of the subtype B strains clustered significantly with
other subtype B strains from Asia (96TH_M041, 97TH_M081,
and 98TH_M145), while two (98TH_M140, and 98TH_M149)
fell outside this cluster, like other subtype B strains from NorthFig. 4. HIV-1 genetic diversity in a mother-to-child transmission cohort from Lampang
the map of Thailand. The proportion of samples with exclusively CRF01_AE probe r
and those considered non-typeable, is shown. (b) Phylogenetic tree based on full-gen
cohort sequences (open circles) and reference sequences (filled circles) are shown. B
clusters within subtype/CRF radiations are also highlighted. (c) MHAbce v2 probe
samples displaying non-CRF01_AE probe reactivity. Color coding is as for Fig. 3.America or Western Europe (Kalish et al., 1994). Further
analysis of the complete genome sequence by bootscanning
showed that the five subtype B strains were non-recombinant
(data not shown). ByMHAbce v.2, four of the subtype B strains,
including the three in the Asian cluster (96TH_M041,
97TH_M081, and 98TH_M145) and one of the Western Bs, Thailand, 1996–1998 (n=180). (a) The Province of Lampang is highlighted on
eactivity in MHAbce v.2, those with at least one non-CRF01_AE probe reacting
ome sequences of samples showing non-CRF01_AE probe reactivity. Lampang
ootstrap values based on 100 replicates are depicted for relevant branches. Asian
reactivity patterns and full-genome sequencing-based genetic structure of 10
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(98TH_M140) was mistyped by the assay, showing mostly
subtype B probes but also one CRF01_AE probe and one
subtype C probe reacting.
The strain clustering with CRF15_01B prototypes
(98TH_M169) showed a structure consistent with this CRF by
bootscanning and sub-region analysis (data not shown). The
outlier strain (98TH_M171), and two of the strains that fell
within the CRF01_AE cluster in the tree (96TH_M005,
96TH_M043), proved to be unique recombinant strains
combining CRF01_AE and subtype B. Two strains that fell
within the CRF01_AE cluster contained more than 90%
CRF01_AE. Strain 96TH_M005 had a small segment of subtype
B in the gag/pol overlap region, and another in the first exon of
tat. Strain 96TH_M043 had small subtype B regions in pol and
nef. The outlier strain (98TH_M171) contained more equal
proportions of subtype B and CRF01_AE, with four breakpoints
across the genome. Fig. 4c shows that the probe hybridization
patterns were mostly consistent with the recombinant structures
derived by bootscanning.
Finally, the strain that showed probe reactivity in the pol
region with both the CRF01_AE and subtype B probes
(98TH_M114) yielded a pure CRF01_AE strain by complete
genome sequencing. Cloning of the pol region of this sample
and examination of several individual clones with MHAbce v.2
showed consistent dual probe reactivity, suggesting that the
strains with dual probe reactivity constituted the majority of the
viral quasispecies present. An infrequent polymorphism at the
probe binding site, not typical of CRF01_AE strains in the
sequence database, was responsible (data not shown).
The comparison of demographic and behavioral variables
between individuals harboring CRF01_AE and non-
CRF01_AE strains showed neither apparent nor significant
differences (data not shown).
In summary, among 180 women attending antenatal clinics
in Lampang Province, Thailand in 1996–1998, the MHAbce v.2
efficiently and correctly identified four subtype B strains, found
a rare CRF15_01B strain, identified three unique B/CRF01_AE
recombinant strains, and showed their detailed structure almost
completely, and identified 167/180 strains as CRF01_AE. Two
strains were mistyped, and three were not typed.
Relationships among unique recombinant forms
The relationship of the newly described B/CRF01_AE re-
combinants to previously described strains from Southeast Asia
was investigated by comparison of the location of breakpoints
separating the segments of different subtypes/CRF (Fig. 5).
The putative CRF15_01B strain shared breakpoints and the
recombinant structure with the prototype strains of this CRF
(Tovanabutra et al., 2003), confirming its typing by MHAbce
v.2. The URFs did not share any breakpoints in common with
each other, but comparison with previously described B/
CRF01_AE URFs revealed several possible shared breakpoints
(Fig. 5). The most extensive network of relationships was
observed for the small segment of subtype B in the first exon of
tat/rev in strain 96TH_M005 from Lampang. The transitionfrom CRF01_AE to subtype B at HXB2 position 5573 and back
to CRF01_AE at HXB2 5968 is also found in strain C2254,
from a community cohort in Chon Buri Province, Thailand in
2000 (Watanaveeradej et al., 2006). Other strains share one of
these breakpoints, but not both. The transition from CRF01_AE
to subtype B at HXB2 5573 is found in OUR740i, and from
subtype B to CRF01_AE at HXB2 5968 is found in OUR033i,
OUR846i and 96THR02; these four strains were found in
injecting drug users in the northern Thailand Province of
Chiang Mai (2001–2002) (Tovanabutra et al., 2004a, 2004b)
and in Bangkok (1996) (Ramos et al., 2002). These results raise
the possibility that a series of related B/CRF01_AE recombi-
nants, with common features but different structures overall,
have been circulating in Thailand since 1996.
The newly described strain 96TH_M043 from Lampang
shared two of its breakpoints with R1741 from Rayong Province
(Watanaveeradej et al., 2006), and one with OUR840i from
ChiangMai (Tovanabutra et al., 2004a, 2004b). Similarly, M171
has points of commonality with 98TH_MU2003SEM, from a
community cohort in Bangkok, OUR740i, and 99TH_OUR2574
from Chiang Mai, and CRF15_01B (Fig. 5). It is quite
interesting that 98TH_M171 and 98TH_MU2003SEM appear
to share three breakpoints in common, suggesting that they may
share a more recent common parental strain.
Discussion
Multi-region hybridization assays (MHAs) represent one
solution to the growing challenge of HIV-1 genotyping in
epidemics where there is co-circulation of different subtypes
and the generation of many different inter-subtype recombinant
strains (Arroyo et al., 2005; Hierholzer et al., 2002; Hoelscher
et al., 2002; Kijak et al., 2004). These assays have been
designed to bridge the gap between characterization of each
HIV-1 strain by sequencing of the entire genome, on the one
hand, and the requirement for adequate sampling of large and
complex epidemics, on the other. A family of MHAs, each with
application to a specific regional epidemic, has been developed
in recent years, includingMHAacd for East Africa (Arroyo et al.,
2005; Hoelscher et al., 2002), MHAcrf02 for West and West
central Africa (Kijak et al., 2004), MHAbf for South America
(Hierholzer et al., 2002), and MHAbce v.1 for application in
Asia (Watanaveeradej et al., 2006). Here we describe the re-
design of the MHAbce assay (MHAbce v.2) to encompass new
information about the diversity of molecular forms of HIV-1
circulating in Asia.
Elements of the newly developed MHAbce v.2 assay include
use of subtype-specific fluorescent probes in eight different
regions of the HIV-1 genome, re-positioning of probes to better
discriminate the many inter-subtype recombinant forms that
have been described, and incorporation of de-stabilizing
mutations within probes, when necessary, to improve specifi-
city. It is also important to note the high throughput of this
assay. Using a 384-well plate format in an ABI7900 HT
Sequence Detection System, 85 strains per week can be
genotyped. This development cycle has resulted in a new,
high-throughput genotyping system that performed with
Fig. 5. Relationship between new and previously described B/CRF01_AE recombinants. (a) Newly described B/CRF01_AE recombinants and previously reported
strains with which they share recombination breakpoints. CRF01_AE and subtype B are shown in black and gray, respectively. (b) List of recombination breakpoints
within newly described recombinants (numbering is according to HXB2 reference sequence). All of the subtype associations were supported by 80% or higher bootstrap
values in the corresponding sub-genomic trees.
187G.H. Kijak et al. / Virology 358 (2007) 178–191sensitivity of greater than 95% and a specificity of nearly 100%
on a panel of 70 strains of known genotype. Remaining
challenges for assay development include evaluation of the
assay on additional strains of B′, a variant of subtype B
common in Asia (Graf et al., 1998; Kalish et al., 1994; Ou et al.,
1992, 1993), and on additional subtype C strains since relatively
few of these were used in the validation panel. The performance
on subtype B strains more typical of epidemics in Western
Europe and the Americas also needs to be evaluated since these
may be present at low levels; in the Lampang cohort, one
Western subtype B strain did not hybridize to three of the eight
probes, and another was mistyped as triple recombinant.
Although the performance on subtype C and C-containing
strains has been excellent so far, more of these need to be
evaluated as well.
We applied the MHAbce v.2 to an important question
pertaining to the emerging inter-subtype recombinant strains in
Thailand. Using a relatively low risk MTCT cohort in Northern
Thailand, the degree of intermixing of CRF01_AE strains with
subtype B and recombinants was evaluated. The results indicate
that, by the period 1996–1998, strains other than CRF01_AEaccounted for more than 5% of infections in this small study of
180 individuals. Moreover, the recombinant strains were as
numerous as the subtype B strains. By comparing the structures
of recombinants with others previously described in the region,
we were able to establish the presence of a CRF15_01B strain in
Lampang Province as early as 1998; this CRFwas first identified
in specimens dated from 1999 to 2002 sampled in Chiang Mai,
Rayong, and Bangkok, but had apparently already circulated to
some extent earlier in the North (Tovanabutra et al., 2003).
In a similar vein, three unique recombinant strains identified
in Lampang in this study shared some of their breakpoints with
other recombinant strains, described later in other regions of the
country (Ramos et al., 2002; Tovanabutra et al., 2003, 2004a,
2004b; Watanaveeradej et al., 2006). Most of these recombinant
strains were found in individuals with injecting drug use as their
main risk for HIV-1 infection, but some were from individuals
with heterosexual risk as well. The interconnection of IDU and
heterosexual networks in Thailand is reinforced by these data.
The identification of groups of recombinant strains that share
some of their breakpoints in common suggests that recombinant
strains may undergo further rounds of recombination, either with
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who are repeatedly exposed to HIV-1 and may become dually
infected can be an important source of these interrelated
recombinant forms. Since none of the women that we studied
in Lampang reported injecting drug use (data not shown), it
remains possible that the B/CRF01_AE recombinant strains that
we found were transmissions from male partners with connec-
tion to IDU networks.
The wider application of the MHAbce v.2 can help to
characterize an important and highly complex epidemic of HIV-1
infection in Asia and may help shed light on the social conditions
that foster the emergence of new recombinant strains. Preparation
for vaccine trials, which can include genotyping of HIV-1 strains
in large cohorts of potential trial volunteers, is another important
application for this approach. The broad geographic area of
application of the assay, including China, India, Southeast Asia,
and many countries of the Pacific Rim, can foster the
development of a comprehensive and detailed picture generated
with a common and standardized genotyping approach of an
important component of the HIV/AIDS pandemic.
Materials and methods
Sequence alignment for assay development
Published full-genome HIV-1 nucleotide sequences from
Asia were retrieved from the Los Alamos National Laboratory
HIV-1 database (http://hiv.lanl.gov). An alignment was built
using ClustalX (Thompson et al., 1997) and was manually
edited using Genetic Data Environment (Smith et al., 1994).
Estimation of hybridization strength of oligonucleotide
duplexes
Candidate strain-specific probes were selected using visual
inspection of nucleotide alignments, and with Primer Express
software v2.0 (Applied Biosystems). The thermal stability of
duplexes between candidate probes and target sequences was
measured by thermal dissociation curves of duplexes formed
between corresponding unlabeled oligonucleotides (Sigma
Genosys, St. Louis, MO) in the presence of SybrGreen (Applied
Biosystems), which fluoresces while bound to double-stranded
DNA. For each genomic region, at least one CRF01_AE-, one
subtype B-, and one subtype C-specific probe were tested.
Additional candidate probes, containing mutations introduced
ad hoc that would increase the specificity by destabilizing the
heteroduplexes, were also tested. For genomic regions where
limited, though consistent, within-clade sequence variation was
observed in probe-binding sites, additional targets that contained
the observed polymorphisms were included. For each unlabeled
probe/target pair, a reaction mix containing 2× TaqMan
SybrGreen PCR Master Mix (Applied Biosystems), 1 μM
probe, 1 μM target, and dH2O was prepared in duplicate.
Dissociation curves were obtained using the following routine in
a 384-well ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems): 95 °C for 15 s, 30 °C for 15 s, and 95 °C
for 15 s, at a 10% ramp rate. Themelting temperature (Tm) of theduplexes was estimated as the maximum of the peak in the
−dRn/dT vs. temperature graph.
MHAbce v.2
The principle of the MHAbce v.2 is to amplify multiple short
fragments throughout the HIV-1 genome and assess the
hybridization of clade-specific fluorescent probes in a real-
time PCR (Hoelscher et al., 2002). The amplified regions were
positioned in areas of the genome that would tend to maximize
discrimination among the different strains of interest (Fig. 1c).
Seven regions of the HIV-1 genome were amplified in separate
first-round PCRs, or RT-PCRs, if the starting material is proviral
DNA or viral RNA, respectively. The evaluated regions lay
within p17, protease (pro), reverse transcriptase (rt), integrase
(int), first exon of tat (tat), C3 in gp120 (gp120), and gp41/nef
(Fig. 1c). The first-round PCR mix contained GeneAmp 10×
PCR Gold Buffer (Applied Biosystems, Foster City, CA),
200 μM each dNTP, 1.5 mM MgCl2, 400 nM of each outer
primer, 1.25 U of AmpliTaq Gold DNA Polymerase (Applied
Biosystems, Foster City, CA), and 5 μl of extracted DNA, in a
final volume of 25 μl. The thermocycle routine was: hold at
95 °C for 10 min, then 30 cycles of 95 °C 10 s, 55 °C 30 s, and
72 °C 1 min, and a final extension at 72 °C for 7 min, in an ABI
9600 thermocycler (Applied Biosystems, Foster City, CA). The
RT-PCR mix contained QIAGEN OneStep RT-PCR 5× Buffer
(Qiagen, Valencia, CA), 200 μM each dNTP, 400 nM of each
outer primer, 4 U of RNasin Ribonuclease Inhibitor (Promega,
Madison, WI), 0.5 μl of QIAGEN OneStep RT-PCR Enzyme
Mix (Qiagen, Valencia, CA), and 5 μl of extracted RNA, in a
final volume of 25 μl. The thermocycle routine was: hold at
50 °C for 30 min, then hold at 95 °C for 15 min, then 30 cycles
of 95 °C 10 s, 55 °C 30 s, and 72 °C 1 min, and a final
extension at 72 °C for 10 min, in an ABI 9600 thermocycler
(Applied Biosystems, Foster City, CA).
An aliquot of each amplicon was then distributed into one (in
the cases of the p17, pro, rt, int, tat, and gp120 regions) or two
(in the case of gp41/nef) separate sets of second-round PCRs.
Second-round PCR was performed in a TaqMan real-time
format, with universal primers, and fluorescent probes specific
for subtypes B, C, or CRF01_AE. Probes for the different
subtypes were used in separate real-time PCRs. The gp120
probes were 5′-end labeled with TET and 3′-end labeled with
Black Hole Quencher (BHQ1). All other probes were 5′-end
labeled with FAM and 3′-end labeled with BHQ1 (Biosource,
Camarillo, CA). Second-round real-time PCR mixes contained
TaqMan 2× Universal PCR Master Mix (Applied Biosystems,
Foster City, CA), 400 nM of each inner primer, 250 nM of
probe, and 2.5 μl of first-round PCR product, in a final volume
of 12.5 μl. Real-time PCR amplification was performed in a
384-well ABI PRISM 7900HT Sequence Detection System
(Applied Biosystem) with the following routine: hold at 95 °C
for 10 min, 40 cycles of 95 °C 15 s, and 60 °C 1 min. In the case
of the gp120 region, the extension step was performed at 60 °C
for 2 min. Fluorescence intensity was monitored during the
reaction and was analyzed using the SDS v2.1 software
(Applied Biosystem). The threshold was set based on negative
189G.H. Kijak et al. / Virology 358 (2007) 178–191controls, and results were considered positive when the
threshold cycle (CT) was lower than 35 and if an exponential
increase in the normalized fluorescence intensity for over five
consecutive cycles was observed.
To assess if negative real-time PCR results were due to lack
of sample amplification or lack of probe hybridization, a parallel
real-time PCR containing 2× SybrGreen PCR Master Mix, and
similar amounts of inner primers and template, was performed
in parallel to determine whether a PCR product had been
generated. The identity of the amplicons was verified by
conducting melting curves (95 °C 15 s, 30 °C 15 s, and 95 °C
15 s, at a 10% ramp rate), which distinguished the expected
PCR products from primer–dimers of lower thermal stability.
Assay validation
A panel of 70 samples, for which a virtually full-genome
sequence had been obtained, was used for assay validation (Table
S1). The panel included subtypes B (n=4), C (n=4), CRF01_AE
(n=45), CRF08_BC (n=1), CRF15_01B (n=4), B/CRF01_AE
URFs (n=11), and C/CRF01_AE URFs (n=1). Samples were
collectedmainly in Thailand, but specimens from India andChina
were also used. Nearly full-genome PCR amplicons were
prepared as previously described (Carr et al., 1999; Salminen et
al., 1995b) and were used for assay validation after dilution to
copy numbers consistent with the range found in primary clinical
samples. In the case of the subtype C isolates, nearly full-genome
amplicons cloned into pCR2.1 vector were obtained through the
AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH from Dr. Kavita Lole, Dr. Robert Bollinger,
and Dr. Stuart Ray. Total DNA from PBMCs obtained from HIV-
1 seronegative donors, and buffer blanks were included as
negative controls (phosphate buffered saline).
Field test of the assay
A retrospective sample set was used to field test MHAbce
v.2. Between 1996 and 1998, volunteers were enrolled in a
prospective perinatal cohort study, aimed at evaluating the roles
of HIV-1 viral burden, and of mucosal and systemic immunity,
on MTCT, in Lampang Province, Northern Thailand. The study
was conducted jointly by the Lampang Hospital (Ministry of
Public Health, Thailand), the Research Institute of Health
Sciences (Chiang Mai University, Thailand), Armed Forces
Research Institute of Medical Research (Royal Thai Army
component and US Army component, Bangkok, Thailand),
Johns Hopkins University (Baltimore, MD, USA), Walter Reed
Army Institute of Research (Rockville, MD, USA), and the
Henry M. Jackson Foundation for the Advancement of Military
Medicine (Rockville, MD, USA). Plasma samples collected
from 180/181 participating HIV-1 infected pregnant women
with an estimated gestational age of at least 15 weeks were
available for subtyping with MHAbce v2. The median age was
24 years (inter-quartile interval: 22–27 years), and the median
viral load was 4.32 log copies/ml (inter-quartile interval: 3.70–
4.77 log copies/ml) (Roche AMPLICOR HIV-1 MONITOR
Test version 1.5, Roche Diagnostics, Indianapolis, IN). Themajority of the participants reported heterosexual sexual
preference (179/180), and none reported previous or current
injection drug use. Seventy three out of 180 women were under
AZT treatment during pregnancy. Viral RNA was extracted
using the MagnaPure robotic nucleic acid extraction procedure
(Roche Diagnostics, Indianapolis, IN), following the manufac-
turer's instructions, and processed according the abovemen-
tioned MHAbce v.2 protocol.
Sequencing and phylogenetic analysis
Near full-length HIV-1 amplicons were generated by nested
PCR from DNA extracted from PBMCs, as previously
described (Carr et al., 1999; Salminen et al., 1995b). Nucleotide
sequencing was carried out with big dye terminators using an
ABI 3100 capillary sequencer (Applied Biosystems), as
described. Sequences were analyzed, edited, and assembled
with Sequencher 3.0 (Ann Arbor, MI). Phylogenetic analysis
was performed using the SEQBOOT, DNADIST, NEIGHBOR,
CONSENSE modules of the Phylip software package (v3.2c),
and with TREETOOL. Bootscanning (Salminen et al., 1995a)
and sub-genomic neighbor joining trees were used to
characterize recombinant strains. Newly described sequences
were deposited in the GenBank under accession numbers
DQ354112–DQ354123.
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